{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:09:50Z","timestamp":1784660990908,"version":"3.55.0"},"reference-count":51,"publisher":"Akademiai Kiado Zrt.","issue":"2","license":[{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["EuJMI"],"published-print":{"date-parts":[[2024,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>APC and TP53 are the two most regularly mutated genes in colon adenocarcinoma (COAD), especially in progressive malignancies and antitumoral immune response. The current bioinformatics analysis investigates the APC and TP53 gene expression profile in colon adenocarcinoma as a prognostic characteristic for survival, particularly concentrating on the correlated immune microenvironment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Clinical and genetic data of colon cancer and normal tissue samples were obtained\u00a0from The Cancer Genome Atlas (TCGA)-COAD and Genotype-Tissue Expression (GTEx) online databases, respectively. The genetic differential expressions were analyzed in both groups via the one-way ANOVA test. Kaplan\u2013Meier survival curves were applied to estimate the overall survival (OS). <jats:italic>P<\/jats:italic> &lt; 0.05 was fixed as statistically significant. On Tumor Immune Estimation Resource and Gene Expression Profiling Interactive Analysis databases, the linkage between immune cell recruitment and APC and TP53 status was assessed through Spearman's correlation analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>APC and TP53 were found mutated in 66.74% and 85.71% of the 454 and 7 TCGA-COAD patients in colon and rectosigmoid junction primary sites, respectively with a higher log2-transcriptome per million reads compared to the GTEx group (318 samples in sigmoid and 368 samples in transverse). Survival curves revealed a worse significant OS for the high-APC and TP53 profile colon. Spearman's analysis of immune cells demonstrated a strong positive correlation between the APC status and infiltration of T\u00a0cell CD4+, T cell CD8+, NK cell, and macrophages and also a positive correlation between status and infiltration of T cell CD4+, T cell CD8+.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>APC and TP53 gene mutations prevail in colon cancer and are extremely associated with poor prognosis and shortest survival. The infiltrating T cell CD4+, T cell CD8+, NK cell, and macrophages populate the colon microenvironment and regulate the mechanisms of tumor advancement, immune evasion, and sensitivity to standard chemotherapy. More comprehensive research is needed to demonstrate these results and turn them into new therapeutic outlooks.<\/jats:p><\/jats:sec>","DOI":"10.1556\/1886.2024.00015","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T11:48:31Z","timestamp":1710244111000},"page":"154-165","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":6,"title":["Immune landscape in APC and TP53 related tumor microenvironment in colon adenocarcinoma: A bioinformatic analysis"],"prefix":"10.1556","volume":"14","author":[{"given":"Arefeh","family":"Zabeti Touchaei","sequence":"first","affiliation":[{"name":"Department of Chemistry, Lahijan Branch, Islamic Azad University, Lahijan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1794-0563","authenticated-orcid":true,"given":"Sogand","family":"Vahidi","sequence":"additional","affiliation":[{"name":"Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2701-9943","authenticated-orcid":true,"given":"Ali Akbar","family":"Samadani","sequence":"additional","affiliation":[{"name":"Guilan Road Trauma Research Center, Trauma Institute, Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"issue":"1","key":"B1","series-title":"Gastroenterology","first-page":"335","article-title":"Global burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold M","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et\u00a0al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335\u201349.e15."},{"issue":"15","key":"B2","series-title":"Sci Adv","article-title":"The tumor suppressor adenomatous polyposis coli regulates T lymphocyte migration","volume":"8","author":"Mastrogiovanni M","year":"2022","unstructured":"Mastrogiovanni M, Vargas P, Rose T, Cuche C, Esposito E, Juzans M, et\u00a0al. The tumor suppressor adenomatous polyposis coli regulates T lymphocyte migration. Sci Adv. 2022;8(15):eabl5942."},{"issue":"2","key":"B3","series-title":"Cancers (Basel)","first-page":"676","article-title":"Epigenetics and colorectal cancer pathogenesis","volume":"5","author":"Bardhan K","year":"2013","unstructured":"Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers (Basel). 2013;5(2):676\u2013713."},{"key":"B4","series-title":"Front Cell Dev Biol","article-title":"A different facet of p53 function: regulation of immunity and inflammation during tumor development","volume":"9","author":"Shi D","year":"2021","unstructured":"Shi D, Jiang P. A different facet of p53 function: regulation of immunity and inflammation during tumor development. Front Cell Dev Biol. 2021;9:762651."},{"issue":"2","key":"B5","series-title":"Med Sci (Basel)","article-title":"Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells","volume":"6","author":"Testa U","year":"2018","unstructured":"Testa U, Pelosi E, Castelli G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med Sci (Basel). 2018;6(2)."},{"issue":"2","key":"B6","series-title":"J Gastrointest Cancer","first-page":"431","article-title":"TERRA gene expression in gastric cancer: role of hTERT","volume":"52","author":"Vahidi S","year":"2021","unstructured":"Vahidi S, Samadani AA. TERRA gene expression in gastric cancer: role of hTERT. J Gastrointest Cancer. 2021;52(2):431\u201347."},{"key":"B7","series-title":"Biomed Pharmacother","article-title":"Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy","volume":"115","author":"Norollahi SE","year":"2019","unstructured":"Norollahi SE, Mansour-Ghanaei F, Joukar F, Ghadarjani S, Mojtahedi K, Gharaei Nejad K, et\u00a0al. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy. Biomed Pharmacother. 2019;115:108958."},{"issue":"1","key":"B8","series-title":"Int J Mol Sci","article-title":"Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements","volume":"22","author":"Malki A","year":"2020","unstructured":"Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S, Al Moustafa AE. Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements. Int J Mol Sci. 2020;22(1)."},{"issue":"1","key":"B9","series-title":"Sci Rep","first-page":"5113","article-title":"Carmel-Gross I, et\u00a0al. Heterozygous APC germline mutations impart predisposition to colorectal cancer","volume":"11","author":"Preisler L","year":"2021","unstructured":"Preisler L, Habib A, Shapira G, Kuznitsov-Yanovsky L, Mayshar Y, Carmel-Gross I, et\u00a0al. Heterozygous APC germline mutations impart predisposition to colorectal cancer. Sci Rep. 2021;11(1):5113."},{"issue":"24","key":"B10","series-title":"Br J Pharmacol","first-page":"4575","article-title":"Molecular regulation and pharmacological targeting of the \u03b2-catenin destruction complex","volume":"174","author":"van Kappel EC","year":"2017","unstructured":"van Kappel EC, Maurice MM. Molecular regulation and pharmacological targeting of the \u03b2-catenin destruction complex. Br J Pharmacol. 2017;174(24):4575\u201388."},{"key":"B11","series-title":"Elife","article-title":"A novel GSK3-regulated APC:Axin interaction regulates Wnt signaling by driving a catalytic cycle of efficient \u03b2catenin destruction","volume":"4","author":"Pronobis MI","year":"2015","unstructured":"Pronobis MI, Rusan NM, Peifer M. A novel GSK3-regulated APC:Axin interaction regulates Wnt signaling by driving a catalytic cycle of efficient \u03b2catenin destruction. Elife. 2015;4:e08022."},{"issue":"1","key":"B12","series-title":"Oncol Rev","first-page":"534","article-title":"Adenomatous polyposis coli in cancer and therapeutic implications","volume":"15","author":"Noe O","year":"2021","unstructured":"Noe O, Filipiak L, Royfman R, Campbell A, Lin L, Hamouda D, et\u00a0al. Adenomatous polyposis coli in cancer and therapeutic implications. Oncol Rev. 2021;15(1):534."},{"issue":"5","key":"B13","series-title":"Cell Rep","first-page":"1370","article-title":"Integrated analysis of TP53 gene and pathway alterations in the cancer genome Atlas","volume":"28","author":"Donehower LA","year":"2019","unstructured":"Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, Cardenas M, et\u00a0al. Integrated analysis of TP53 gene and pathway alterations in the cancer genome Atlas. Cell Rep. 2019;28(5):1370\u201384.e5."},{"issue":"5","key":"B14","series-title":"Cold Spring Harb Perspect Med","article-title":"Tumor-suppressor functions of the TP53 pathway","volume":"6","author":"Aubrey BJ","year":"2016","unstructured":"Aubrey BJ, Strasser A, Kelly GL. Tumor-suppressor functions of the TP53 pathway. Cold Spring Harb Perspect Med. 2016;6(5)."},{"issue":"5","key":"B15","series-title":"Cell Death Differ","first-page":"961","article-title":"Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?","volume":"29","author":"Thomas AF","year":"2022","unstructured":"Thomas AF, Kelly GL, Strasser A. Of the many cellular responses activated by TP53, which ones are critical for tumour suppression? Cell Death Differ. 2022;29(5):961\u201371."},{"issue":"1","key":"B16","series-title":"Signal Transduct Target Ther","first-page":"92","article-title":"Targeting p53 pathways: mechanisms, structures, and advances in therapy","volume":"8","author":"Wang H","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8(1):92."},{"issue":"8","key":"B17","series-title":"Nucleic Acids Res","first-page":"e71","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico A","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et\u00a0al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71."},{"key":"B18","series-title":"Gut","article-title":"APC\u00a0and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer","author":"Tian Y","year":"2023","unstructured":"Tian Y, Wang X, Cramer Z, Rhoades J, Estep KN, Ma X, et\u00a0al. APC\u00a0and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer. Gut. 2023."},{"issue":"21","key":"B19","series-title":"Cancers (Basel)","article-title":"APC and TP53 mutations predict cetuximab sensitivity across consensus molecular subtypes","volume":"13","author":"Thota R","year":"2021","unstructured":"Thota R, Yang M, Pflieger L, Schell MJ, Rajan M, Davis TB, et\u00a0al. APC and TP53 mutations predict cetuximab sensitivity across consensus molecular subtypes. Cancers (Basel). 2021;13(21)."},{"issue":"19","key":"B20","series-title":"Cancers (Basel)","article-title":"Use of personalized biomarkers in metastatic colorectal cancer and the impact of AI","volume":"14","author":"Volovat SR","year":"2022","unstructured":"Volovat SR, Augustin I, Zob D, Boboc D, Amurariti F, Volovat C, et\u00a0al. Use of personalized biomarkers in metastatic colorectal cancer and the impact of AI. Cancers (Basel). 2022;14(19)."},{"issue":"1","key":"B21","series-title":"Cancer Metastasis Rev","first-page":"159","article-title":"Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting","volume":"37","author":"Hankey W","year":"2018","unstructured":"Hankey W, Frankel WL, Groden J. Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer Metastasis Rev. 2018;37(1):159\u201372."},{"key":"B22","series-title":"J Coloproctol (Rio de Janeiro)","first-page":"135","article-title":"The fluctuation of APC gene in WNT signaling with adenine deletion of adenomatous polyposis coli, is associated in colorectal cancer","volume":"40","author":"Norollahi SE","year":"2020","unstructured":"Norollahi SE, Hamidian SMT, Kohpar ZK, Azadi R, Rostami P, Vahidi S, et\u00a0al. The fluctuation of APC gene in WNT signaling with adenine deletion of adenomatous polyposis coli, is associated in colorectal cancer. J Coloproctol (Rio de Janeiro). 2020;40:135\u201342."},{"issue":"1","key":"B23","series-title":"Cancer Cell Int","first-page":"703","article-title":"p53 signaling in cancer progression and therapy","volume":"21","author":"Marei HE","year":"2021","unstructured":"Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Pozzoli G, et\u00a0al. p53 signaling in cancer progression and therapy. Cancer Cell Int. 2021;21(1):703."},{"issue":"1","key":"B24","series-title":"Infect Agent Cancer","first-page":"48","article-title":"Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer","volume":"18","author":"Dadgar-Zankbar L","year":"2023","unstructured":"Dadgar-Zankbar L, Shariati A, Bostanghadiri N, Elahi Z, Mirkalantari S, Razavi S, et\u00a0al. Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer. Infect Agent Cancer. 2023;18(1):48."},{"issue":"3","key":"B25","series-title":"Oncol Rep","first-page":"1281","article-title":"Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients","volume":"35","author":"Al-Khayal K","year":"2016","unstructured":"Al-Khayal K, Abdulla M, Al-Obeed O, Al Kattan W, Zubaidi A, Vaali-Mohammed MA, et\u00a0al. Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients. Oncol Rep. 2016;35(3):1281\u20136."},{"key":"B26","series-title":"Braz J Biol","article-title":"Alterations in APC, BECN1, and TP53 gene expression levels in colon cancer cells caused by monosodium glutamate","volume":"83","author":"Al Hargan A","year":"2021","unstructured":"Al Hargan A, Daghestani MH, Harrath AH. Alterations in APC, BECN1, and TP53 gene expression levels in colon cancer cells caused by monosodium glutamate. Braz J Biol. 2021;83:e246970."},{"issue":"16","key":"B27","series-title":"World J Gastroenterol","first-page":"2359","article-title":"Future therapeutic implications of new molecular mechanism of colorectal cancer","volume":"29","author":"Lu S","year":"2023","unstructured":"Lu S, Jia CY, Yang JS. Future therapeutic implications of new molecular mechanism of colorectal cancer. World J Gastroenterol. 2023;29(16):2359\u201368."},{"issue":"11\u201312","key":"B28","series-title":"Genes Dev","first-page":"787","article-title":"Genetic and biological hallmarks of colorectal cancer","volume":"35","author":"Li J","year":"2021","unstructured":"Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev. 2021;35(11\u201312):787\u2013820."},{"issue":"1","key":"B29","series-title":"J Gastrointest Oncol","first-page":"170","article-title":"Immunotherapy in colorectal cancer: for the select few or all?","volume":"9","author":"Arora SP","year":"2018","unstructured":"Arora SP, Mahalingam D. Immunotherapy in colorectal cancer: for the select few or all? J Gastrointest Oncol. 2018;9(1):170\u20139."},{"issue":"23","key":"B30","series-title":"JCI Insight","article-title":"Molecular profiling identifies distinct subtypes across TP53 mutant tumors","volume":"7","author":"Chen X","year":"2022","unstructured":"Chen X, Liu T, Wu J, Zhu C, Guan G, Zou C, et\u00a0al. Molecular profiling identifies distinct subtypes across TP53 mutant tumors. JCI Insight. 2022;7(23)."},{"key":"B31","series-title":"J Oncol","article-title":"Identification of APC mutation as a potential predictor for immunotherapy in colorectal cancer","volume":"2022","author":"Feng F","year":"2022","unstructured":"Feng F, Sun H, Zhao Z, Sun C, Zhao Y, Lin H, et\u00a0al. Identification of APC mutation as a potential predictor for immunotherapy in colorectal cancer. J Oncol. 2022;2022:6567998."},{"issue":"3","key":"B32","series-title":"Oncol Lett","first-page":"3159","article-title":"Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer","volume":"18","author":"Liu Y","year":"2019","unstructured":"Liu Y, Xu F, Wang Y, Wu Q, Wang B, Yao Y, et\u00a0al. Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer. Oncol Lett. 2019;18(3):3159\u201369."},{"issue":"6","key":"B33","series-title":"Hepatobiliary Surg Nutr","first-page":"705","article-title":"Impact and clinical usefulness of genetic data in the\u00a0surgical management of colorectal cancer liver metastasis: a\u00a0narrative review","volume":"9","author":"Margonis GA","year":"2020","unstructured":"Margonis GA, Kreis ME, Wang JJ, Kamphues C, Wolfgang CL, Weiss MJ. Impact and clinical usefulness of genetic data in the\u00a0surgical management of colorectal cancer liver metastasis: a\u00a0narrative review. Hepatobiliary Surg Nutr. 2020;9(6):705\u201316."},{"issue":"6","key":"B34","series-title":"Br J Cancer","first-page":"979","article-title":"Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer","volume":"113","author":"Jorissen RN","year":"2015","unstructured":"Jorissen RN, Christie M, Mouradov D, Sakthianandeswaren A, Li S, Love C, et\u00a0al. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer. Br J Cancer. 2015;113(6):979\u201388."},{"issue":"1","key":"B35","series-title":"Sci Rep","first-page":"8154","article-title":"Enhancing the landscape of colorectal cancer using targeted deep sequencing","volume":"11","author":"Lee CS","year":"2021","unstructured":"Lee CS, Song IH, Lee A, Kang J, Lee YS, Lee IK, et\u00a0al. Enhancing the landscape of colorectal cancer using targeted deep sequencing. Sci Rep. 2021;11(1):8154."},{"issue":"10","key":"B36","series-title":"Biomedicines","article-title":"Genetic alterations of metastatic colorectal cancer","volume":"8","author":"Testa U","year":"2020","unstructured":"Testa U, Castelli G, Pelosi E. Genetic alterations of metastatic colorectal cancer. Biomedicines. 2020;8(10)."},{"issue":"8","key":"B37","series-title":"J Natl Cancer Inst","article-title":"Multiple roles of APC and its therapeutic implications in colorectal cancer","volume":"109","author":"Zhang L","year":"2017","unstructured":"Zhang L, Shay JW. Multiple roles of APC and its therapeutic implications in colorectal cancer. J Natl Cancer Inst. 2017;109(8)."},{"issue":"5","key":"B38","series-title":"Leukemia","first-page":"1500","article-title":"STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma","volume":"35","author":"Lobello C","year":"2021","unstructured":"Lobello C, Tichy B, Bystry V, Radova L, Filip D, Mraz M, et\u00a0al. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia. 2021;35(5):1500\u20135."},{"issue":"1","key":"B39","series-title":"BMC Gastroenterol","first-page":"95","article-title":"APC mutation correlated with poor response of immunotherapy in colon cancer","volume":"23","author":"Li B","year":"2023","unstructured":"Li B, Zhang G, Xu X. APC mutation correlated with poor response of immunotherapy in colon cancer. BMC Gastroenterol. 2023;23(1):95."},{"key":"B40","series-title":"EBioMedicine","article-title":"TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection","volume":"58","author":"Klinakis A","year":"2020","unstructured":"Klinakis A, Rampias T. TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection. EBioMedicine. 2020;58:102905."},{"key":"B41","series-title":"Front Immunol","first-page":"501","article-title":"Modulation of APC function and anti-tumor immunity by anti-cancer drugs","volume":"6","author":"Martin K","year":"2015","unstructured":"Martin K, Schreiner J, Zippelius A. Modulation of APC function and anti-tumor immunity by anti-cancer drugs. Front Immunol. 2015;6:501."},{"issue":"5","key":"B42","series-title":"Oncol Lett","first-page":"4155","article-title":"Tumor infiltrating lymphocytes: the regulator of melanoma evolution","volume":"17","author":"Antohe M","year":"2019","unstructured":"Antohe M, Nedelcu RI, Nichita L, Popp CG, Cioplea M, Brinzea A, et\u00a0al. Tumor infiltrating lymphocytes: the regulator of melanoma evolution. Oncol Lett. 2019;17(5):4155\u201361."},{"key":"B43","series-title":"Elife","first-page":"12","article-title":"Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis","author":"Wu X","year":"2023","unstructured":"Wu X, Yan H, Qiu M, Qu X, Wang J, Xu S, et\u00a0al. Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis. Elife. 2023;12."},{"key":"B44","series-title":"Front Immunol","article-title":"Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment","volume":"13","author":"Zheng X","year":"2022","unstructured":"Zheng X, Ma Y, Bai Y, Huang T, Lv X, Deng J, et\u00a0al. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment. Front Immunol. 2022;13:984480."},{"key":"B45","series-title":"Pathol Oncol Res","article-title":"The role of tumor microenvironment and immune response in colorectal cancer development and prognosis","volume":"28","author":"Wozniakova M","year":"2022","unstructured":"Wozniakova M, Skarda J, Raska M. The role of tumor microenvironment and immune response in colorectal cancer development and prognosis. Pathol Oncol Res. 2022;28:1610502."},{"key":"B46","series-title":"Front Immunol","article-title":"Advances in immunotyping of colorectal cancer","volume":"14","author":"Wu Y","year":"2023","unstructured":"Wu Y, Zhuang J, Qu Z, Yang X, Han S. Advances in immunotyping of colorectal cancer. Front Immunol. 2023;14:1259461."},{"issue":"21","key":"B47","series-title":"Febs j","first-page":"4160","article-title":"The influence of microenvironment on tumor immunotherapy","volume":"286","author":"Zhang J","year":"2019","unstructured":"Zhang J, Shi Z, Xu X, Yu Z, Mi J. The influence of microenvironment on tumor immunotherapy. Febs j. 2019;286(21):4160\u201375."},{"issue":"4","key":"B48","series-title":"J Gastrointest Oncol","first-page":"1786","article-title":"The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds","volume":"12","author":"Duan X","year":"2021","unstructured":"Duan X, Cai Y, He T, Shi X, Zhao J, Zhang H, et\u00a0al. The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds. J Gastrointest Oncol. 2021;12(4):1786\u201396."},{"issue":"7","key":"B49","series-title":"Nat Genet","first-page":"963","article-title":"Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer","volume":"54","author":"Joanito I","year":"2022","unstructured":"Joanito I, Wirapati P, Zhao N, Nawaz Z, Yeo G, Lee F, et\u00a0al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat Genet. 2022;54(7):963\u201375."},{"key":"B50","series-title":"Front Immunol","first-page":"369","article-title":"Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer","volume":"11","author":"Picard E","year":"2020","unstructured":"Picard E, Verschoor CP, Ma GW, Pawelec G. Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer. Front Immunol. 2020;11:369."},{"key":"B51","series-title":"Transl Oncol","article-title":"Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care","volume":"38","author":"Xiao Y","year":"2023","unstructured":"Xiao Y, Li ZZ, Zhong NN, Cao LM, Liu B, Bu LL. Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care. Transl Oncol. 2023;38:101794."}],"container-title":["European Journal of Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/1886\/14\/2\/article-p154.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/1886\/14\/2\/article-p154.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/1886\/14\/2\/article-p154.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:06:37Z","timestamp":1715706397000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/1886\/14\/2\/article-p154.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":51,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1556\/1886.2024.00015","relation":{},"ISSN":["2062-509X","2062-8633"],"issn-type":[{"value":"2062-509X","type":"print"},{"value":"2062-8633","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,14]]}}}